Longitudinal Immune Profiling Reveals Key Immune Signatures Associated with COVID-19

Madhvi Menon will discuss immune profiling of COVID-19 patients and Jyoti Phatak-Sheldon will highlight the use of RNAscope in situ hybridization in SARS-CoV-2 research.

The Scientist Creative Services Team
Sep 14, 2020

FREE Webinar

Tuesday, October 6, 2020
2:30 - 4:00 PM, Eastern Standard Time

Register Now

COVID-19 pathogenesis is associated with an exaggerated immune response. However, the specific cellular mediators and inflammatory components driving diverse clinical disease outcomes remain poorly understood. In this webinar sponsored by Advanced Cell Diagnostics (ACD), Madhvi Menon will describe the longitudinal immune profiling of hospitalized patients during the peak of the COVID-19 pandemic in the UK, and the key immune signatures that associated with disease severity. Additionally, Jyoti Phatak-Sheldon will describe what researchers can learn about COVID-19 using ACD’s RNAscope in situ hybridization technology with RNA probes specific for SARS-CoV-2.

Topics to be covered

  • Immune profiling of COVID-19 patients in the UK
  • Immune signatures associated with severe COVID-19
  • Changes in immune signatures after recovery
  • RNAscope in situ hybridization technology specific for SARS-CoV-2

Register Now

Meet the speakers:

Madhvi Menon, PhD
Presidential Research Fellow
School of Biological Sciences
University of Manchester

Jyoti Phatak-Sheldon
Associate Scientist, Applications
Advanced Cell Diagnostics, a Bio-Techne Brand